Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs Combination vs No Treatment Post-SLT
NCT06498440Phase 4Not yet recruiting
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Sep 2024
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac tromethamine, fluorometholone in post-operative inflammation, postoperative pain, sponsored by St. Joseph's Healthcare Hamilton. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
ketorolac tromethaminefluorometholone
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT06498440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06498440.